$2.15
-0.14-6.11%
Pre-Market: 8:27 AM EDT
Comments
Loading...
BioXcel Therapeutics Stock Guidance | NASDAQ:BTAI | Benzinga
BioXcel Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BioXcel Therapeutics Inc (BTAI) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for BioXcel Therapeutics (BTAI)?
There have been no specific sales or earnings guidance reported for BioXcel Therapeutics in recent months.
Browse guidance and forecast on all stocks.